サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1547106

アレルギー注射市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年

Allergy Shots Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 309 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
アレルギー注射市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年
出版日: 2024年08月27日
発行: Persistence Market Research
ページ情報: 英文 309 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchはこのほど、アレルギー注射の世界市場に関する包括的なレポートを発表しました。本レポートでは、促進要因・動向・機会・課題を含む重要な市場ダイナミクスを徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主要な洞察

  • アレルギー注射の市場規模（2024年）：28億7,590万米ドル
  • 予測市場金額（2033年）：64億7,270万米ドル
  • 世界市場成長率（CAGR 2024年～2033年）：9.4%

アレルギー注射市場 - 調査範囲

アレルゲン免疫療法としても知られるアレルギー注射は、特定のアレルゲンに対する免疫系を徐々に減感作することによってアレルギー反応を治療するために使用されます。これらの注射は数ヶ月から数年にわたり投与され、花粉、ダニ、カビ、ペットのフケなどの物質に対するアレルギーを管理するために使用されます。同市場は、病院、診療所、アレルギー専門センター、在宅ケアの現場に対応し、さまざまな治療レジメンと製剤を提供しています。

市場成長の促進力は、アレルギー疾患の有病率の増加、ヘルスケア支出の増加、免疫療法技術の進歩による治療効果と患者の転帰の向上です。

市場成長の促進要因：

世界のアレルギー注射市場は、アレルギー疾患の罹患率の増加や、効果的な治療オプションとしてのアレルゲン免疫療法に対する認識の高まりなど、いくつかの主要な要因によって推進されています。アレルギー性鼻炎、喘息、その他のアレルギー疾患の有病率の上昇が市場拡大に寄与しています。また、より効果的で個別化されたアレルゲン抽出物の開発や投与技術の向上などの技術的進歩も、市場成長の原動力となっています。さらに、長期的な解決策を求める患者の間でアレルギー注射の採用が増加しており、対症療法薬への依存度が低下していることも、市場の需要をさらに促進しています。

市場抑制要因：

有望な成長見通しにもかかわらず、アレルギー注射市場は治療期間、コスト、患者のコンプライアンスに関する課題に直面しています。治療期間が長く、ヘルスケアプロバイダーを頻繁に訪れる必要があるため、アレルギー注射を敬遠する患者もいます。治療費が高く、アレルゲン免疫療法に対する保険適用が限られていることも、特にヘルスケア予算に制約のある新興国での市場浸透に影響を与える可能性があります。これらの障壁に対処するには、患者教育の強化、手頃な治療オプションへのアクセスの改善、アレルゲン免疫療法の保険適用拡大が必要です。

市場機会：

アレルギー注射市場は、技術革新、人口動向、ヘルスケア提供モデルの進化によって大きな成長機会がもたらされます。アレルギー検査と診断ツールの進歩により、患者の特定と治療のカスタマイズが改善されつつあります。さらに、モバイルヘルスアプリケーションや遠隔医療プラットフォームなどのデジタルヘルス技術の統合により、患者のアレルギー治療へのアクセスや治療のアドヒアランスが向上しています。食物アレルギーや慢性副鼻腔炎への応用の可能性など、アレルゲン免疫療法の適応拡大が市場範囲を広げ、技術革新を刺激しています。

本レポートで扱う主要な質問

  • アレルギー注射市場の世界的成長を促進する主要な要因は何か？
  • アレルゲン免疫療法技術の進歩は市場力学にどのような影響を与えているか？
  • アレルギー注射市場が直面する主要な課題は何か、またどのように対処できるか？
  • アレルギー注射市場の主要企業はどこで、市場の関連性を維持するためにどのような戦略を採用しているのか？
  • 世界のアレルギー注射市場における新たな動向と将来展望は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲 / 分類
  • 市場の定義 / 範囲 / 制限
  • 包含事項・除外事項

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 製品イノベーション / 開発動向

第4章 主要な成功要因

  • 製品の採用 / 使用状況分析
  • 製品のUSP / 特徴
  • パイプライン評価
  • 最近の製品承認と発売
  • PESTLE分析
  • ポーターの分析
  • 規制シナリオ
  • バリューチェーン分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • ダイナミクス

第6章 COVID-19危機 - 影響評価

  • COVID-19と影響分析
    • 製品別
    • 免疫療法別
    • 適応症
    • アレルゲン別
    • 流通チャネル別
    • 地域別
  • 2024年の市場シナリオ

第7章 世界市場数量（単位）分析

  • 過去の数量（単位）分析、2019年～2023年
  • 現在および将来の数量（単位）予測、2024年～2033年
    • 前年比成長動向分析

第8章 世界市場 - 価格分析

  • 地域別価格分析：製品別
  • 価格の内訳
    • メーカーレベルの価格設定
    • ディストリビューターレベルの価格設定
  • 世界平均価格分析ベンチマーク
  • 価格設定の前提

第9章 世界市場の需要（金額または規模、百万米ドル）分析

  • 過去の市場金額（百万米ドル）分析、2019年～2023年
  • 現在および将来の市場金額（百万米ドル）予測、2024年～2033年
    • 前年比成長動向分析
    • 絶対額の機会分析

第10章 世界市場分析、製品別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）と数量（単位）の分析、製品別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）と数量（単位）の分析と予測、製品別、2024年～2033年
    • SLITタブレット
    • 経口
    • 注射
    • その他
  • 市場の魅力分析：製品別

第11章 世界市場分析、免疫療法別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）分析、免疫療法別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測、免疫療法別、2024年～2033年
    • 舌下免疫療法（SLIT）
    • 皮下免疫療法（SCIT）
    • その他
  • 市場の魅力分析：免疫療法別

第12章 世界市場分析、適応症別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析、適応症別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測、適応症別、2024年～2033年
    • アレルギー性鼻炎
    • アレルギー性喘息
    • 食物アレルギー
    • アトピー性皮膚炎
    • その他
  • 市場の魅力分析：適応症別

第13章 世界市場分析、アレルゲン別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）分析、アレルゲン別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）分析と予測、アレルゲン別、2024年～2033年
    • 花粉
    • ハウスダストダニ（HDM）
    • 型
    • 動物のふけ
    • 蜂毒
    • ゴキブリ / 昆虫
    • その他
  • 市場の魅力分析：アレルゲン別

第14章 世界市場分析、流通チャネル別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析、流通チャネル別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測、流通チャネル別、2024年～2033年
    • 機関投資家向け販売
    • 小売販売
  • 市場の魅力分析：流通チャネル別

第15章 世界市場分析：地域別

  • イントロダクション
  • 過去の市場規模（百万米ドル）の分析、地域別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測、地域別、2024年～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東・アフリカ（MEA）
  • 市場の魅力分析：地域別

第16章 北米市場分析

第17章 ラテンアメリカ市場分析

第18章 欧州市場分析

第19章 南アジア市場分析

第20章 東アジア市場分析

第21章 オセアニア市場分析

第22章 中東・アフリカ市場分析

第23章 市場構造分析

  • 市場分析：企業階層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第24章 競合分析

  • 競合ダッシュボード
  • ブランディングとプロモーション戦略
  • 主要開発分析
  • 競合の詳細情報
    • ALK Abello
    • Stallergenes Greer
    • Allergy Therapeutics
    • Aimmune Therapeutics
    • Anergis
    • Arrayit Corporation
    • Biomay AG
    • HAL Allergy Group
    • DBV Technologies

第25章 使用される前提条件と頭字語

第26章 調査手法

目次
Product Code: PMRREP31924

Persistence Market Research has recently released a comprehensive report on the worldwide market for allergy shots. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Allergy Shots Market Size (2024E): USD 2,875.9 million
  • Projected Market Value (2033F): USD 6,472.7 million
  • Global Market Growth Rate (CAGR 2024 to 2033): 9.4%

Allergy Shots Market - Report Scope:

Allergy shots, also known as allergen immunotherapy, are used to treat allergic reactions by gradually desensitizing the immune system to specific allergens. These shots are administered over a period of months or years and are used to manage allergies to substances such as pollen, dust mites, mold, and pet dander. The market caters to hospitals, clinics, specialized allergy centers, and homecare settings, offering various treatment regimens and formulations.

Market growth is driven by an increasing prevalence of allergic disorders, rising healthcare expenditures, and advancements in immunotherapy techniques, enhancing treatment efficacy and patient outcomes.

Market Growth Drivers:

The global allergy shots market is propelled by several key factors, including the growing incidence of allergic diseases and an increasing awareness of allergen immunotherapy as an effective treatment option. The rising prevalence of allergic rhinitis, asthma, and other allergic conditions is contributing to market expansion. Technological advancements, such as the development of more effective and personalized allergen extracts and improvements in administration techniques, are also driving market growth. Additionally, the growing adoption of allergy shots among patients seeking long-term solutions and reduced dependency on symptomatic medications further fuels market demand.

Market Restraints:

Despite promising growth prospects, the allergy shots market faces challenges related to treatment duration, cost, and patient compliance. The lengthy treatment duration and the need for frequent visits to healthcare providers can deter some patients from pursuing allergy shots. High treatment costs and limited insurance coverage for allergen immunotherapy may also impact market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these barriers requires enhanced patient education, improved access to affordable treatment options, and greater insurance coverage for allergen immunotherapy.

Market Opportunities:

The allergy shots market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. Advances in allergy testing and diagnostic tools are improving patient identification and treatment customization. Additionally, the integration of digital health technologies, such as mobile health applications and telemedicine platforms, enhances patient access to allergy care and treatment adherence. Expanding indications for allergen immunotherapy, including potential applications for food allergies and chronic sinusitis, broadens the market scope and stimulates innovation.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the allergy shots market globally?
  • How are advancements in allergen immunotherapy techniques influencing market dynamics?
  • What are the key challenges faced by the allergy shots market, and how can they be addressed?
  • Who are the leading players in the allergy shots market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global allergy shots market?

Competitive Intelligence and Business Strategy:

Leading players in the global allergy shots market, including companies such as Allergy Therapeutics, Stallergenes Greer, and HAL Allergy, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced allergen extracts and delivery systems, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical research institutions, and regulatory agencies facilitate market access and promote technology adoption. Emphasis on clinical research, evidence-based practice, and patient education is essential to drive market growth and enhance patient outcomes in the evolving allergy shots landscape.

Key Companies Profiled:

  • Allergy Therapeutics
  • Stallergenes Greer
  • HAL Allergy
  • Merck & Co., Inc.
  • Novartis AG
  • Antigen Laboratories
  • ALK-Abello A/S
  • DBV Technologies
  • Schering-Plough Corporation
  • Mylan N.V.

Key Segments Covered in Allergy Shots Industry Research

Product:

  • SLIT Tablets
  • Oral
  • Injections

Immunotherapy:

  • Sublingual Immunotherapy (SLIT)
  • Subcutaneous Immunotherapy (SCIT)
  • Specific Immunotherapy

Indication:

  • Allergic Rhinitis
  • Allergic Asthma
  • Food Allergy
  • Atopic Dermatitis

Allergen:

  • Pollens
  • House Dust Mites (HDM)
  • Mold
  • Animal Dander
  • Bee Venom
  • Cockroaches/Insects

Distribution Channel:

  • Institutional Sales
  • Retail Sales

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Pipeline Assessment
  • 4.4. Recent Product Approval and Launches
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis
  • 4.7. Regulatory Scenario
  • 4.8. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Allergy Diagnostics Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Growth of the Top Companies
    • 5.2.2. Rising Prevalence of Various Types of Allergies
    • 5.2.3. Cost of Products
    • 5.2.4. Product and Stock Availability
    • 5.2.5. Mergers and Acquisitions
    • 5.2.6. Changing Lifestyle
    • 5.2.7. Strong Product Pipeline
    • 5.2.8. Growing Corporate Agreements
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Immunotherapy
    • 6.1.3. BY Indication
    • 6.1.4. By Allergen
    • 6.1.5. By Distribution Channel
    • 6.1.6. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Volume (in Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Volume (in Units) Analysis, 2019-2023
  • 7.2. Current and Future Volume (in Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
    • 10.3.1. SLIT Tablets
      • 10.3.1.1. Odactra
      • 10.3.1.2. Grastek
      • 10.3.1.3. Ragwitek
      • 10.3.1.4. Oralair
      • 10.3.1.5. Actair
      • 10.3.1.6. Others
    • 10.3.2. Oral
      • 10.3.2.1. Palforzia
      • 10.3.2.2. Others
    • 10.3.3. Injections
    • 10.3.4. Others
  • 10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Immunotherapy

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By Immunotherapy, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Immunotherapy, 2024-2033
    • 11.3.1. Sublingual Immunotherapy (SLIT)
    • 11.3.2. Subcutaneous Immunotherapy (SCIT)
      • 11.3.2.1. Specific Immunotherapy
    • 11.3.3. Others
  • 11.4. Market Attractiveness Analysis By Immunotherapy

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Indication

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis By Indication, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2024-2033
    • 12.3.1. Allergic Rhinitis
    • 12.3.2. Allergic Asthma
    • 12.3.3. Food Allergy
    • 12.3.4. Atopic Dermatitis
    • 12.3.5. Others
  • 12.4. Market Attractiveness Analysis By Indication

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Allergen

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Mn) Analysis By Allergen, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Allergen, 2024-2033
    • 13.3.1. Pollens
      • 13.3.1.1. Grass Pollens
      • 13.3.1.2. Weed Pollens
      • 13.3.1.3. Tree Pollens
    • 13.3.2. House Dust Mites (HDM)
    • 13.3.3. Mould
    • 13.3.4. Animal Dander
    • 13.3.5. Bee Venom
    • 13.3.6. Cockroaches/Insects
    • 13.3.7. Others
  • 13.4. Market Attractiveness Analysis By Allergen

14. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Distribution Channel

  • 14.1. Introduction / Key Findings
  • 14.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2024-2033
    • 14.3.1. Institutional Sales
      • 14.3.1.1. Government Hospitals
      • 14.3.1.2. Semi-Government Hospitals
      • 14.3.1.3. Private Hospitals
    • 14.3.2. Retail Sales
      • 14.3.2.1. Retail Pharmacy
      • 14.3.2.2. Drug Stores
      • 14.3.2.3. Online Pharmacy
  • 14.4. Market Attractiveness Analysis By Distribution Channel

15. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2033
    • 15.3.1. North America
    • 15.3.2. Latin America
    • 15.3.3. Europe
    • 15.3.4. South Asia
    • 15.3.5. East Asia
    • 15.3.6. Oceania
    • 15.3.7. Middle East and Africa (MEA)
  • 15.4. Market Attractiveness Analysis By Region

16. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. U.S.
      • 16.3.1.2. Canada
    • 16.3.2. By Product
    • 16.3.3. By Immunotherapy
    • 16.3.4. By Indication
    • 16.3.5. By Allergen
    • 16.3.6. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Immunotherapy
    • 16.4.4. By Indication
    • 16.4.5. By Allergen
    • 16.4.6. By Distribution Channel
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. U.S. Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Product
        • 16.5.1.2.2. By Immunotherapy
        • 16.5.1.2.3. By Indication
        • 16.5.1.2.4. By Allergen
        • 16.5.1.2.5. By Distribution Channel
    • 16.5.2. Canada Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Product
        • 16.5.2.2.2. By Immunotherapy
        • 16.5.2.2.3. By Indication
        • 16.5.2.2.4. By Allergen
        • 16.5.2.2.5. By Distribution Channel
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Brazil
      • 17.3.1.2. Mexico
      • 17.3.1.3. Argentina
      • 17.3.1.4. Rest of Latin America
    • 17.3.2. By Product
    • 17.3.3. By Immunotherapy
    • 17.3.4. By Indication
    • 17.3.5. By Allergen
    • 17.3.6. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Immunotherapy
    • 17.4.4. By Indication
    • 17.4.5. By Allergen
    • 17.4.6. By Distribution Channel
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. Brazil Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Product
        • 17.5.1.2.2. By Immunotherapy
        • 17.5.1.2.3. By Indication
        • 17.5.1.2.4. By Allergen
        • 17.5.1.2.5. By Distribution Channel
    • 17.5.2. Mexico Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Product
        • 17.5.2.2.2. By Immunotherapy
        • 17.5.2.2.3. By Indication
        • 17.5.2.2.4. By Allergen
        • 17.5.2.2.5. By Distribution Channel
    • 17.5.3. Argentina Market Analysis
      • 17.5.3.1. Introduction
      • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.3.2.1. By Product
        • 17.5.3.2.2. By Immunotherapy
        • 17.5.3.2.3. By Indication
        • 17.5.3.2.4. By Allergen
        • 17.5.3.2.5. By Distribution Channel
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Germany
      • 18.3.1.2. France
      • 18.3.1.3. Italy
      • 18.3.1.4. U.K.
      • 18.3.1.5. Spain
      • 18.3.1.6. Russia
      • 18.3.1.7. BENELUX
      • 18.3.1.8. Rest of Europe
    • 18.3.2. By Product
    • 18.3.3. By Immunotherapy
    • 18.3.4. By Indication
    • 18.3.5. By Allergen
    • 18.3.6. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Immunotherapy
    • 18.4.4. By Indication
    • 18.4.5. By Allergen
    • 18.4.6. By Distribution Channel
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. Germany Market Analysis
      • 18.5.1.1. Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Product
        • 18.5.1.2.2. By Immunotherapy
        • 18.5.1.2.3. By Indication
        • 18.5.1.2.4. By Allergen
        • 18.5.1.2.5. By Distribution Channel
    • 18.5.2. France Market Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Product
        • 18.5.2.2.2. By Immunotherapy
        • 18.5.2.2.3. By Indication
        • 18.5.2.2.4. By Allergen
        • 18.5.2.2.5. By Distribution Channel
    • 18.5.3. Italy Market Analysis
      • 18.5.3.1. Introduction
      • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.3.2.1. By Product
        • 18.5.3.2.2. By Immunotherapy
        • 18.5.3.2.3. By Indication
        • 18.5.3.2.4. By Allergen
        • 18.5.3.2.5. By Distribution Channel
    • 18.5.4. U.K. Market Analysis
      • 18.5.4.1. Introduction
      • 18.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.4.2.1. By Product
        • 18.5.4.2.2. By Immunotherapy
        • 18.5.4.2.3. By Indication
        • 18.5.4.2.4. By Allergen
        • 18.5.4.2.5. By Distribution Channel
    • 18.5.5. Spain Market Analysis
      • 18.5.5.1. Introduction
      • 18.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.5.2.1. By Product
        • 18.5.5.2.2. By Immunotherapy
        • 18.5.5.2.3. By Indication
        • 18.5.5.2.4. By Allergen
        • 18.5.5.2.5. By Distribution Channel
    • 18.5.6. Russia Market Analysis
      • 18.5.6.1. Introduction
      • 18.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.6.2.1. By Product
        • 18.5.6.2.2. By Immunotherapy
        • 18.5.6.2.3. By Indication
        • 18.5.6.2.4. By Allergen
        • 18.5.6.2.5. By Distribution Channel
    • 18.5.7. BENELUX Market Analysis
      • 18.5.7.1. Introduction
      • 18.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.7.2.1. By Product
        • 18.5.7.2.2. By Immunotherapy
        • 18.5.7.2.3. By Indication
        • 18.5.7.2.4. By Allergen
        • 18.5.7.2.5. By Distribution Channel
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. India
      • 19.3.1.2. Thailand
      • 19.3.1.3. Indonesia
      • 19.3.1.4. Malaysia
      • 19.3.1.5. Rest of South Asia
    • 19.3.2. By Product
    • 19.3.3. By Immunotherapy
    • 19.3.4. By Indication
    • 19.3.5. By Allergen
    • 19.3.6. By Distribution Channel
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Immunotherapy
    • 19.4.4. By Indication
    • 19.4.5. By Allergen
    • 19.4.6. By Distribution Channel
  • 19.5. Country Level Analysis & Forecast
    • 19.5.1. India Market Analysis
      • 19.5.1.1. Introduction
      • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.1.2.1. By Product
        • 19.5.1.2.2. By Immunotherapy
        • 19.5.1.2.3. By Indication
        • 19.5.1.2.4. By Allergen
        • 19.5.1.2.5. By Distribution Channel
    • 19.5.2. Thailand Market Analysis
      • 19.5.2.1. Introduction
      • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.2.2.1. By Product
        • 19.5.2.2.2. By Immunotherapy
        • 19.5.2.2.3. By Indication
        • 19.5.2.2.4. By Distribution Channel
    • 19.5.3. Indonesia Market Analysis
      • 19.5.3.1. Introduction
      • 19.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.3.2.1. By Product
        • 19.5.3.2.2. By Immunotherapy
        • 19.5.3.2.3. By Indication
        • 19.5.3.2.4. By Allergen
        • 19.5.3.2.5. By Distribution Channel
    • 19.5.4. Malaysia Market Analysis
      • 19.5.4.1. Introduction
      • 19.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.4.2.1. By Product
        • 19.5.4.2.2. By Immunotherapy
        • 19.5.4.2.3. By Indication
        • 19.5.4.2.4. By Allergen
        • 19.5.4.2.5. By Distribution Channel
  • 19.6. Market Trends
  • 19.7. Key Market Participants - Intensity Mapping
  • 19.8. Drivers and Restraints - Impact Analysis

20. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. China
      • 20.3.1.2. Japan
      • 20.3.1.3. South Korea
    • 20.3.2. By Product
    • 20.3.3. By Immunotherapy
    • 20.3.4. By Indication
    • 20.3.5. By Allergen
    • 20.3.6. By Distribution Channel
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Immunotherapy
    • 20.4.4. By Indication
    • 20.4.5. By Allergen
    • 20.4.6. By Distribution Channel
  • 20.5. Country Level Analysis & Forecast
    • 20.5.1. China Market Analysis
      • 20.5.1.1. Introduction
      • 20.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.5.1.2.1. By Product
        • 20.5.1.2.2. By Immunotherapy
        • 20.5.1.2.3. By Indication
        • 20.5.1.2.4. By Allergen
        • 20.5.1.2.5. By Distribution Channel
    • 20.5.2. Japan Market Analysis
      • 20.5.2.1. Introduction
      • 20.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.5.2.2.1. By Product
        • 20.5.2.2.2. By Immunotherapy
        • 20.5.2.2.3. By Indication
        • 20.5.2.2.4. By Allergen
        • 20.5.2.2.5. By Distribution Channel
    • 20.5.3. South Korea Market Analysis
      • 20.5.3.1. Introduction
      • 20.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.5.3.2.1. By Product
        • 20.5.3.2.2. By Immunotherapy
        • 20.5.3.2.3. By Indication
        • 20.5.3.2.4. By Allergen
        • 20.5.3.2.5. By Distribution Channel
  • 20.6. Market Trends
  • 20.7. Key Market Participants - Intensity Mapping
  • 20.8. Drivers and Restraints - Impact Analysis

21. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 21.1. Introduction
  • 21.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 21.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 21.3.1. By Country
      • 21.3.1.1. Australia
      • 21.3.1.2. New Zealand
    • 21.3.2. By Product
    • 21.3.3. By Immunotherapy
    • 21.3.4. By Indication
    • 21.3.5. By Allergen
    • 21.3.6. By Distribution Channel
  • 21.4. Market Attractiveness Analysis
    • 21.4.1. By Country
    • 21.4.2. By Product
    • 21.4.3. By Immunotherapy
    • 21.4.4. By Indication
    • 21.4.5. By Allergen
    • 21.4.6. By Distribution Channel
  • 21.5. Country Level Analysis & Forecast
    • 21.5.1. Australia Market Analysis
      • 21.5.1.1. Introduction
      • 21.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 21.5.1.2.1. By Product
        • 21.5.1.2.2. By Immunotherapy
        • 21.5.1.2.3. By Indication
        • 21.5.1.2.4. By Allergen
        • 21.5.1.2.5. By Distribution Channel
    • 21.5.2. New Zealand Market Analysis
      • 21.5.2.1. Introduction
      • 21.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 21.5.2.2.1. By Product
        • 21.5.2.2.2. By Immunotherapy
        • 21.5.2.2.3. By Indication
        • 21.5.2.2.4. By Allergen
        • 21.5.2.2.5. By Distribution Channel
  • 21.6. Market Trends
  • 21.7. Key Market Participants - Intensity Mapping
  • 21.8. Drivers and Restraints - Impact Analysis

22. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 22.1. Introduction
  • 22.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 22.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 22.3.1. By Country
      • 22.3.1.1. GCC Countries
      • 22.3.1.2. Turkiye
      • 22.3.1.3. Northern Africa
      • 22.3.1.4. South Africa
      • 22.3.1.5. Rest of Middle East and Africa
    • 22.3.2. By Product
    • 22.3.3. By Immunotherapy
    • 22.3.4. By Indication
    • 22.3.5. By Allergen
    • 22.3.6. By Distribution Channel
  • 22.4. Market Attractiveness Analysis
    • 22.4.1. By Country
    • 22.4.2. By Product
    • 22.4.3. By Immunotherapy
    • 22.4.4. By Indication
    • 22.4.5. By Allergen
    • 22.4.6. By Distribution Channel
  • 22.5. Country Level Analysis & Forecast
    • 22.5.1. GCC Countries Market Analysis
      • 22.5.1.1. Introduction
      • 22.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 22.5.1.2.1. By Product
        • 22.5.1.2.2. By Immunotherapy
        • 22.5.1.2.3. By Indication
        • 22.5.1.2.4. By Allergen
        • 22.5.1.2.5. By Distribution Channel
    • 22.5.2. Turkiye Market Analysis
      • 22.5.2.1. Introduction
      • 22.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 22.5.2.2.1. By Product
        • 22.5.2.2.2. By Immunotherapy
        • 22.5.2.2.3. By Indication
        • 22.5.2.2.4. By Allergen
        • 22.5.2.2.5. By Distribution Channel
    • 22.5.3. Northern Africa Market Analysis
      • 22.5.3.1. Introduction
      • 22.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 22.5.3.2.1. By Product
        • 22.5.3.2.2. By Immunotherapy
        • 22.5.3.2.3. By Indication
        • 22.5.3.2.4. By Allergen
        • 22.5.3.2.5. By Distribution Channel
    • 22.5.4. South Africa Market Analysis
      • 22.5.4.1. Introduction
      • 22.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 22.5.4.2.1. By Product
        • 22.5.4.2.2. By Immunotherapy
        • 22.5.4.2.3. By Indication
        • 22.5.4.2.4. By Allergen
        • 22.5.4.2.5. By Distribution Channel
  • 22.6. Market Trends
  • 22.7. Key Market Participants - Intensity Mapping
  • 22.8. Drivers and Restraints - Impact Analysis

23. Market Structure Analysis

  • 23.1. Market Analysis by Tier of Companies
  • 23.2. Market Share Analysis of Top Players
  • 23.3. Market Presence Analysis

24. Competition Analysis

  • 24.1. Competition Dashboard
  • 24.2. Branding and Promotional Strategies
  • 24.3. Key Development Analysis
  • 24.4. Competition Deep Dive
    • 24.4.1. ALK Abello
      • 24.4.1.1. Overview
      • 24.4.1.2. Product Portfolio
      • 24.4.1.3. Key Financials
      • 24.4.1.4. SWOT Analysis
      • 24.4.1.5. Sales Footprint
      • 24.4.1.6. Strategy Overview
    • 24.4.2. Stallergenes Greer
      • 24.4.2.1. Overview
      • 24.4.2.2. Product Portfolio
      • 24.4.2.3. Key Financials
      • 24.4.2.4. SWOT Analysis
      • 24.4.2.5. Sales Footprint
      • 24.4.2.6. Strategy Overview
    • 24.4.3. Allergy Therapeutics
      • 24.4.3.1. Overview
      • 24.4.3.2. Product Portfolio
      • 24.4.3.3. Key Financials
      • 24.4.3.4. SWOT Analysis
      • 24.4.3.5. Sales Footprint
      • 24.4.3.6. Strategy Overview
    • 24.4.4. Aimmune Therapeutics
      • 24.4.4.1. Overview
      • 24.4.4.2. Product Portfolio
      • 24.4.4.3. Key Financials
      • 24.4.4.4. SWOT Analysis
      • 24.4.4.5. Sales Footprint
      • 24.4.4.6. Strategy Overview
    • 24.4.5. Anergis
      • 24.4.5.1. Overview
      • 24.4.5.2. Product Portfolio
      • 24.4.5.3. Key Financials
      • 24.4.5.4. SWOT Analysis
      • 24.4.5.5. Sales Footprint
      • 24.4.5.6. Strategy Overview
    • 24.4.6. Arrayit Corporation
      • 24.4.6.1. Overview
      • 24.4.6.2. Product Portfolio
      • 24.4.6.3. Key Financials
      • 24.4.6.4. SWOT Analysis
      • 24.4.6.5. Sales Footprint
      • 24.4.6.6. Strategy Overview
    • 24.4.7. Biomay AG
      • 24.4.7.1. Overview
      • 24.4.7.2. Product Portfolio
      • 24.4.7.3. Key Financials
      • 24.4.7.4. SWOT Analysis
      • 24.4.7.5. Sales Footprint
      • 24.4.7.6. Strategy Overview
    • 24.4.8. HAL Allergy Group
      • 24.4.8.1. Overview
      • 24.4.8.2. Product Portfolio
      • 24.4.8.3. Key Financials
      • 24.4.8.4. SWOT Analysis
      • 24.4.8.5. Sales Footprint
      • 24.4.8.6. Strategy Overview
    • 24.4.9. DBV Technologies
      • 24.4.9.1. Overview
      • 24.4.9.2. Product Portfolio
      • 24.4.9.3. Key Financials
      • 24.4.9.4. SWOT Analysis
      • 24.4.9.5. Sales Footprint
      • 24.4.9.6. Strategy Overview

25. Assumptions and Acronyms Used

26. Research Methodology